Methods and compositions relating to regression-associated antig

Details Methods and compositions relating to regression-associated antig Methods and compositions relating to regression-associated antig

1986-03-07

1988-05-31

Marantz, Sidney

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

424 85, 424 88, 435 29, 436536, 436543, 436548, 436813, 530350, 530387, 530403, 530412, 530413, C07K 300, C07K 1500, G01N 3353, G01N 33574

Patent

active

047481129

ABSTRACT:
Regression associated antigens are identified in material from neoplastic cells by their immunological reactivity with regression associated antibodies from the serum of patients diagnosed as undergoing regression of a tumor. Regression associated antibodies are identified by their absence during progression of a neoplastic disease state and by their presence in a diagnosed state of regression. The antigens are purified, used to monitor the condition of cancer patients, and production of antibodies and treatments employing those antibodies are described.

REFERENCES:
patent: 4340535 (1982-07-01), Voisin
patent: 4383985 (1983-05-01), Bartorelli
patent: 4452904 (1984-06-01), Haagensen, Jr.
patent: 4472509 (1984-09-01), Gansow
patent: 4517303 (1985-05-01), Freytag
patent: 4543211 (1985-09-01), Kato
patent: 4559311 (1985-12-01), Stenman
patent: 4562160 (1985-12-01), Real
patent: 4584268 (1986-04-01), Ceriani
Ben-Aissa et al., Br. J. Cancer, 52, 65-72 (1985).
Bubbers et al., Bull. Cancer, 68, 332-337 (1981).
Capony et al., Biochem. Biophys. Res. Commun., 108, 8-15 (1982).
Du Bois et al., J. Immunol. Methods, 63, 7-24 (1983).
Feit et al., Cancer Res., 44, 5752-5756 (1984).
Giard et al., J. Nat. Cancer Inst., 51, 1417-1423 (1973).
Herrmann et al. J. Cell Sci, 73, 87-103 (1985).
Hood et al. Immunology, Benjamin/Cummings Publishing Co., 510-529, (1984).
Juillard et al. Cancer, 41, 2215-2225 (1978).
Juillard et al. Bull. Cancer, 66, 217-228 (1979).
Kohler et al. Nature, 256, 495-496 (1975).
Lachmann et al.
Br. J. Cancer, 51, 415-417 (1985).
Laemmli Nature, 227, 680-685 (1970).
Laucius et al. Cancer, 40, 2091-2093 (1977).
Lowder et al. Western J. Med., 143, 810-818 (1985).
Mule et al. J. Immunol. 135, 646-652 (1985).
Sell Monoclonal Antibodies and Cancer Therapy, A. R. Liss, Inc., New York, 3-21 (1985).
Rodwell et al. Biotechnology, 3, 889-894 (1985).
Rosenberg et al. New Engl. J. Med., 313, 1485-1492 (1985).
Sen et al. Proc. Natl. Acad. Sci. (USA), 80, 1246-1250 (1983).
Schlom et al. Cancer, 54, 2777-2794 (1984).
Springer Science, 224, 1198-1206 (1984).
Towbin et al. Proc. Natl. Acad. Sci., (USA), 76, 4350-4354 (1979).
Wallack et al. Surgery, 96, 791-800 (1984).
Weisenburger et al. J. Biol. Resp. Mod., 1, 57-66 (1982).

Affiliated with

Also associated with

Rating

Methods and compositions relating to regression-associated antig does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and compositions relating to regression-associated antig, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions relating to regression-associated antig will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1874110